Literature DB >> 11045600

Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice.

Y F Ueng1, C C Shyu, Y L Lin, S S Park, J F Liao, C F Chen.   

Abstract

Effects of baicalein and wogonin, the major flavonoids of Scutellariae radix, on cytochrome P450 (CYP), UDP-glucuronosyl transferase (UGT), and glutathione S-transferase (GST) were studied in C57BL/6J mice. One-week treatment of mice with a liquid diet containing 5 mM baicalein resulted in 29%, 14%, 36%, 28%, and 46% decreases of hepatic benzo(a)pyrene hydroxylation (AHH), benzphetamine N-demethylation (BDM), N-nitrosodimethylamine N-demethylation (NDM), nifedipine oxidation (NFO), and erythromycin N-demethylation (EMDM) activities, respectively. Treatment with a liquid diet containing 5 mM wogonin resulted in 43%, 22%, 21%, 24%, and 35% decreases of hepatic AHH, BDM, NDM, NFO, and EMDM activities, respectively. However, hepatic 7-methoxyresorufin O-demethylation (MROD) activity was increased and decreased by baicalein- and wogonin-treatments, respectively. Similar modulation was observed with caffeine 3-demethylation (CDM) activity. Immunoblot analysis showed that the levels of hepatic CYP2E1 and CYP3A proteins were decreased by both baicalein- and wogonin-treatments. Hepatic CYP1A2 protein level was increased by baicalein but decreased by wogonin. In extrahepatic tissues, renal AHH activity was decreased by wogonin whereas pulmonary AHH, 7-ethoxyresorufin O-deethylation (EROD), and MROD activities were increased by both flavonoids. Both baicalein and wogonin strongly increased CYP1A protein level in mouse lung. Hepatic and renal UGT activities toward p-nitrophenol were suppressed by baicalein- and wogonin-treatments. However, cytosolic GST activity was not affected by flavonoids. These results suggest that ingestion of baicalein or wogonin can modulate drug-metabolizing enzymes and the modulation shows tissue specificity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045600     DOI: 10.1016/s0024-3205(00)00809-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.

Authors:  Wen Jiang; Ming Hu
Journal:  RSC Adv       Date:  2012-09-21       Impact factor: 3.361

2.  Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes.

Authors:  Tingting Li; Ning Li; Qinglong Guo; Hui Ji; Di Zhao; Shan Xie; Xiaonan Li; Zhixia Qiu; Deen Han; Xijing Chen; Qidong You
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-29       Impact factor: 2.441

3.  Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of wogonin and oroxylin A by human liver and intestinal microsomes.

Authors:  Qiong Zhou; Zhijie Zheng; Bijun Xia; Lan Tang; Chang Lv; Wei Liu; Zhongqiu Liu; Ming Hu
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

4.  Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity.

Authors:  Tung-Yuan Shih; Ton-Ho Young; Herng-Sheng Lee; Chung-Bao Hsieh; Oliver Yoa-Pu Hu
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

5.  Inhibitory Effects of Scutellaria baicalensis Root Extract on Linoleic Acid Hydroperoxide-induced Lung Mitochondrial Lipid Peroxidation and Antioxidant Activities.

Authors:  Pei Ru Liau; Ming Shun Wu; Ching Kuo Lee
Journal:  Molecules       Date:  2019-06-06       Impact factor: 4.411

6.  Inhibitory effects of daiokanzoto (da-huang-gan-cao-tang) on p-glycoprotein.

Authors:  Yuka Watanabe; Nobutomo Ikarashi; Toshiyuki Satoh; Kiyomi Ito; Wataru Ochiai; Kiyoshi Sugiyama
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

7.  Application of Scutellariae radix, Gardeniae fructus, and Probiotics to Prevent Salmonella enterica Serovar Choleraesuis Infection in Swine.

Authors:  Chiung-Hung Chang; Yueh-Sheng Chen; Ming-Tang Chiou; Chiu-Hsian Su; Daniel S Chen; Chin-En Tsai; Bi Yu; Yuan-Man Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-26       Impact factor: 2.629

8.  Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats.

Authors:  Xin Tian; Zhen-Yu Cheng; Han Jin; Jie Gao; Hai-Ling Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.